TY - CHAP M1 - Book, Section TI - Menopause and Perimenopausal Issues A1 - Kaufman, Leah A2 - Silverman, Robert K. Y1 - 2017 N1 - T2 - Obesity Medicine: Management of Obesity in Women's Health Care AB - Menopause is defined as the natural end to a woman’s menstrual cycle at the average age of 51 years and ranging between 45 and 55 years.1 This period of time may also be associated with physiologic symptoms, such as vasomotor symptoms or “hot flashes,” mood lability, anxiety, depression, weight gain, insomnia, and fatigue. Many of these symptoms have been attributed to the menopausal transition secondary to a decline in ovarian function.1 The percentage of obese individuals in our population can be assessed through the National Health and Nutrition Examination Survey (NHANES). The 2011–2012 survey data were assessed for body mass index (BMI) stratification2; they revealed that 33.9% of US adults aged 20 years and older were overweight, 35.1% were obese, and 6.4% were extremely obese, with a BMI greater than or equal to 40. These numbers jump significantly in the perimenopausal period. When assessed in the NHANES data set last so stratified in 2007 (showing no change in trends since 2003–2004), 41.1% of women aged 40–59 were obese compared to 30.5% aged 20–39 years. When evaluated by ethnicity, 53% of non-Hispanic black women, 51% of Mexican women, and 39% of non-Hispanic white women aged 40–59 were obese. Over age 60, these numbers increased to 61% for non-Hispanic black women but decreased to 37% for both non-Hispanic white and Mexican women.3 Baseline obesity can affect many of the symptoms described as well as potentially affect the perimenopausal-to-menopausal transition.1 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/19 UR - obgyn.mhmedical.com/content.aspx?aid=1139758971 ER -